Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Olfaction

Olfaction

The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Generalizable MRI normative modelling to detect age-inappropriate neurodegeneration.

Alzheimer's research & therapy·2025

Same author

Retired contact sports athletes with cognitive concerns: promoting lifelong brain health.

Practical neurology·2025

Same author

Targeted non-invasive brain stimulation boosts attention and modulates contralesional brain networks following right hemisphere stroke.

NeuroImage. Clinical·2024

Same author

Brain volume abnormalities and clinical outcomes following paediatric traumatic brain injury.

Brain : a journal of neurology·2022

Same author

Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury.

Science translational medicine·2021

Same author

White matter abnormalities in active elite adult rugby players.

Brain communications·2021

Search research articles

Related Experiment Video

Updated: May 15, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

Auditory cortical function during verbal episodic memory encoding in Alzheimer's disease.

Novraj S Dhanjal¹, Jane E Warren, Maneesh C Patel

¹Division of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, United Kingdom. novraj.dhanjal@imperial.ac.uk

Annals of Neurology

|January 3, 2013

Summary

This summary is machine-generated.

Episodic memory impairment in Alzheimer's disease (AD) is linked to auditory cortex dysfunction. Treatment with a cholinesterase inhibitor (ChI) partially reversed this, improving verbal memory.

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

Related Experiment Videos

Last Updated: May 15, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

Area of Science:

Neuroscience
Cognitive Science
Medical Imaging

Background:

Episodic memory encoding relies on auditory attention and semantic processing.
Auditory cortex activity is modulated by sustained attention.
Previous studies show auditory cortex modulation during attention.

Purpose of the Study:

Investigate human auditory cortex response during sentence encoding for episodic memory.
Examine this response in patients with mild cognitive impairment (MCI) and probable Alzheimer's disease (pAD).

Main Methods:

Functional magnetic resonance imaging (fMRI) was used.
31 healthy participants, 18 MCI patients, and 18 pAD patients were studied.
Participants heard factual sentences; retrieval performance assessed encoding.

Main Results:

Healthy subjects showed auditory cortical response suppression correlated with successful encoding and semantic system activity.
MCI patients exhibited reduced auditory cortical suppression; pAD patients showed no suppression.
Cholinesterase inhibitor (ChI) partially restored suppression in pAD patients, improving verbal memory.

Conclusions:

Verbal episodic memory deficits in Alzheimer's disease (AD) involve altered auditory cortical function.
This impairment is partially reversible with a cholinesterase inhibitor (ChI).
Findings suggest potential pathology in the auditory cortex or impaired neocortical feedback affecting attention and semantic processing.